ProfoundBio raised $112 million to support development of its pipeline of antibody-drug conjugates (ADCs), agents that recognize a molecular target via… Read More
Editor’s note: William Canestaro is managing director at Seattle venture capital firm WRF Capital and leads the biotechnology investment team. … Read More
Prenuvo, the celebrity-endorsed company offering $2,500 full-body MRI scans designed to detect cancer and other diseases early, is planning to… Read More
Seattle-based Icosavax, a spin-out from the University of Washington’s Institute for Protein Design, will be acquired by biotech giant AstraZeneca for… Read More
Valant Medical Solutions, a Seattle startup that develops software to help behavioral health practitioners manage billing and electronic medical records at their… Read More
With revenues declining and net losses increasing, Seattle-based Adaptive Biotechnologies on Thursday said it hired Goldman Sachs to help conduct… Read More
